拉尼比祖马布治疗糖尿病黄斑的参与者的种族和视力结果:元分析
M Ali Khan1,2, Lauren Hill3, Ivaylo Stoilov3
1Department of Research, Wills Eye Hospital, Philadelphia, Pennsylvania.
JAMA ophthalmology
|April 10, 2025
概括
用拉尼比祖马布治疗糖尿病黄斑 (DME) 的视力结果显示黑人和白人患者之间的初始差异. 24个月后,视力敏度相似,这表明种族不会影响长期拉尼比祖马布对DME的有效性.
科学领域:
- 眼科医生 眼科 眼科
- 临床研究 临床研究
- 药物治疗 药物治疗
背景情况:
- 糖尿病黄斑 (DME) 是糖尿病患者视力丧失的主要原因.
- 抗血管内皮生长因子 (抗VEGF) 疗法,如拉尼比祖马布,是DME的标准治疗方法.
- 在治疗反应中潜在的种族差异需要调查.
研究的目的:
- 为了评估种族对Ranibizumab治疗的DME患者视力结果的影响.
- 在临床试验中,黑人和白人参与者之间比较拉尼比祖马布的疗效.
主要方法:
- 五项随机临床试验的元分析,涉及用于DME的拉尼比祖马布.
- 从基线到24个月之间的最佳校正视敏度 (BCVA) 变化在种族子组之间的比较.
- 使用了基线BCVA和倾向性得分匹配的统计调整.
主要成果:
- 黑人参与者基线BCVA比白人参与者更好.
- 24个月的BCVA平均变化与基线相比,与白人参与者相比,黑人参与者的变化较小.
- 在倾向分数匹配后,黑人和白人参与者之间没有观察到BCVA变化的显著差异.
结论:
- 虽然基线视力敏度不同,但对DME的拉尼比祖马布治疗在黑人和白人参与者之间在24个月后导致了类似的视觉结果.
- 该研究强调了临床试验中需要多元化的代表性,因为其他种族群体的入学人数较少阻止了分析.
- 拉尼比祖马布在研究的种族群体中似乎是对DME的有效治疗方法,没有观察到显著的长期差异.
相关概念视频
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65


